These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2715994)

  • 1. Fetal distress associated with the anticardiolipin antibody and a history of intrauterine fetal demise. A case report.
    Greenspoon JS; Buchanan D
    J Reprod Med; 1989 Apr; 34(4):311-4. PubMed ID: 2715994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.
    Lockshin MD; Druzin ML; Goei S; Qamar T; Magid MS; Jovanovic L; Ferenc M
    N Engl J Med; 1985 Jul; 313(3):152-6. PubMed ID: 3925336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus.
    Loizou S; Byron MA; Englert HJ; David J; Hughes GR; Walport MJ
    Q J Med; 1988 Jul; 68(255):525-31. PubMed ID: 3252304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A maternal death due to thrombotic disease associated with anticardiolipin antibody.
    Bendon RW; Wilson J; Getahun B; van der Bel-Kahn J
    Arch Pathol Lab Med; 1987 Apr; 111(4):370-2. PubMed ID: 3827544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy.
    Pattison NS; McKay EJ; Liggins GC; Lubbe WF
    N Z Med J; 1987 Feb; 100(817):61-4. PubMed ID: 3103033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy and lupus: prognostic indicators and response to treatment.
    Englert HJ; Derue GM; Loizou S; Hawkins DF; Elder MG; De Swiet M; Walport MJ; Hughes GR
    Q J Med; 1988 Feb; 66(250):125-36. PubMed ID: 3174925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody to cardiolipin, lupus anticoagulant, and fetal death.
    Lockshin MD; Qamar T; Druzin ML; Goei S
    J Rheumatol; 1987 Apr; 14(2):259-62. PubMed ID: 3110418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing role of the nonstress test in the management of postdates pregnancy.
    Phelan JP; Platt LD; Yeh SY; Trujillo M; Paul RH
    Obstet Gynecol; 1984 Nov; 64(5):624-8. PubMed ID: 6493655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiolipin beta2-glycoprotein I antibody: is a high titer related to unfavorable pregnancy outcome?
    Yamada H; Kato EH; Morikawa M; Shimada S; Ebina Y; Sakuragi N; Suzuki S; Minakami H
    Semin Thromb Hemost; 2003 Dec; 29(6):639-43. PubMed ID: 14719180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome. Influence of antiphospholipid antibody titer, prior pregnancy losses and treatment.
    Reece EA; Garofalo J; Zheng XZ; Assimakopoulos E
    J Reprod Med; 1997 Jan; 42(1):49-55. PubMed ID: 9018646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant.
    Druzin ML; Lockshin M; Edersheim TG; Hutson JM; Krauss AL; Kogut E
    Am J Obstet Gynecol; 1987 Dec; 157(6):1503-10. PubMed ID: 3122577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental thrombosis in experimental anticardiolipin antibodies-mediated intrauterine fetal death.
    Velayuthaprabhu S; Archunan G; Balakrishnan K
    Am J Reprod Immunol; 2007 Apr; 57(4):270-6. PubMed ID: 17362388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study of antiphospholipid antibodies in 50 cases of bad obstetric history.
    Kaneria MV; Vishwanathan C
    J Assoc Physicians India; 1999 Jul; 47(7):669-72. PubMed ID: 10778583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of a nonreactive nonstress test in a twin gestation. A case report.
    Newton ER; Genest DR; Cetrulo CL
    J Reprod Med; 1983 May; 28(5):345-8. PubMed ID: 6152990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine fetal volvulus presenting as fetal distress on cardiotocographic monitoring: a case report.
    Craig S; Easton M
    J Perinat Med; 1998; 26(3):244-7. PubMed ID: 9773388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal surveillance. Should it begin at 40 weeks' gestation in a low-risk population?
    Rosen DJ; Michaeli G; Markov S; Greenspoon JS; Goldberger SB; Fejgin MD
    J Reprod Med; 1995 Feb; 40(2):135-9. PubMed ID: 7738924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical autoimmune disease and recurrent spontaneous abortion.
    Parke A; Maier D; Hakim C; Randolph J; Andreoli J
    J Rheumatol; 1986 Dec; 13(6):1178-80. PubMed ID: 3560107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine fetal death in twins after 32 weeks of gestation.
    Knuppel RA; Rattan PK; Scerbo JC; O'Brien WF
    Obstet Gynecol; 1985 Feb; 65(2):172-5. PubMed ID: 3969231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunology in medical practice. II. Antiphospholipid antibodies in pregnancy].
    Derksen RH; Christiaens GC; Kater L
    Ned Tijdschr Geneeskd; 1997 Sep; 141(37):1769-73. PubMed ID: 9545725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sucessful pregnancy outcome following three severe placental abruptions and intrauterine fetal death in the patient--heterozygous carrier of R506Q mutation of factor V (Leiden)].
    Dimitrova V; Koleva R; Savov A; Chernev T; Khranov Iu; Georgiev G; Slŭncheva B; Raĭcheva S
    Akush Ginekol (Sofiia); 2004; 43(5):47-54. PubMed ID: 15518286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.